SwiftDx

📍 Cambridge, United Kingdom👥 8 employees💰 Last funded Apr 2017

Here at SwiftDx, we're a molecular diagnostic company aiming to revolutionise the field of diagnostics, making it accessible to everybody and everywhere. We are developing novel technology for cost-effective, rapid, easy-to-use and highly specific “yes or no” tests that can be performed directly by the side of the patient in under 15 minutes. We have developed an industry-leading method of high-sensitivity lateral flow DNA detection, enabling the detection of low levels of specific DNA sequences without the need for additional sample processing or expensive DNA amplification methods. Alongside this, our technology has made it possible for ultra-low levels of targets to be detected, enabling highly sensitive lateral flow diagnostics for diseases which are undetectable with current lateral flow technologies.

Total investors

Early stage

Mid stage

Late stage

—

Founded